Recently FDA-confirmed
FDA-confirmed
CosACTHen®
- Species
- Dogs
- Condition
- FDA-confirmed approval
- Stage
- FDA approved
For the evaluation of adrenal function in dogs.
View evidenceManufacturer profile
Dechra, Ltd.
Roxee groups catalog medications and public Innovation Watch records tied to this manufacturer, FDA sponsor, or disclosed development sponsor.
- Catalog meds
- 0
- Innovation records
- 2
- Species
- Dogs
- Latest public update
- Dec 18, 2025
Veterinary professional?
Care category grouping
Where this maker appears in Roxee
No care category grouping has been assigned for this maker yet.
Medication catalog
0 catalog records
No public catalog records are grouped here yet
Roxee may still show Innovation Watch updates if public sponsor evidence exists.
Innovation Watch
2 public updates
Development-stage products may not be FDA-approved, available, or proven safe/effective. Roxee only shows public evidence-backed stage labels.
Recently FDA-confirmed
FDA-confirmed
Otiserene®
- Species
- Dogs
- Condition
- Infection
- Stage
- FDA approved
For the treatment of otitis externa associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria ( Staphylococcus pseudintermedius ) in dogs.
View evidence